Literature DB >> 25856733

A practical review for cardiac rehabilitation professionals of continuous-flow left ventricular assist devices: historical and current perspectives.

Leonida Compostella1, Nicola Russo, Tiziana Setzu, Tomaso Bottio, Caterina Compostella, Vincenzo Tarzia, Ugolino Livi, Gino Gerosa, Sabino Iliceto, Fabio Bellotto.   

Abstract

An increasing number of patients with end-stage heart failure are being treated with continuous-flow left ventricular assist devices (cf-LVADs). These patients provide new challenges to the staff in exercise-based cardiac rehabilitation (CR) programs. Even though experience remains limited, it seems that patients supported by cf-LVADs may safely engage in typical rehabilitative activities, provided that some attention is paid to specific aspects, such as the presence of a short external drive line. In spite of initial physical deconditioning, CR allows progressive improvement of symptoms such as fatigue and dyspnea. Intensity of rehabilitative activities should ideally be based on measured aerobic capacity and increased appropriately over time. Regular, long-term exercise training results in improved physical fitness and survival rates. Appropriate adjustment of cf-LVAD settings, together with maintenance of adequate blood volume, provides maximal output, while avoiding suction effects. Ventricular arrhythmias, although not necessarily constituting an immediate life-threatening situation, deserve treatment as they could lead to an increased rate of hospitalization and poorer quality of life. Atrial fibrillation may worsen symptoms of right ventricular failure and reduce exercise tolerance. Blood pressure measurements are possible in cf-LVAD patients only using a Doppler technique, and a mean blood pressure ≤80 mmHg is considered "ideal." Some patients may present with orthostatic intolerance, related to autonomic dysfunction. While exercise training constitutes the basic rehabilitative tool, a comprehensive intervention that includes psychological and social support could better meet the complex needs of patients in which cf-LVAD may offer prolonged survival.

Entities:  

Mesh:

Year:  2015        PMID: 25856733     DOI: 10.1097/HCR.0000000000000113

Source DB:  PubMed          Journal:  J Cardiopulm Rehabil Prev        ISSN: 1932-7501            Impact factor:   2.081


  1 in total

1.  Patterns and predictors of dyspnoea following left ventricular assist device implantation.

Authors:  Kenneth M Faulkner; Corrine Y Jurgens; Quin E Denfeld; Christopher V Chien; Jessica Harman Thompson; Jill M Gelow; Kathleen L Grady; Christopher S Lee
Journal:  Eur J Cardiovasc Nurs       Date:  2022-10-14       Impact factor: 3.593

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.